NCT05780515View on ClinicalTrials.gov

A Study of ANX009 in Adult Participants With Lupus Nephritis

PHASE1CompletedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

August 9, 2022

Primary Completion Date

August 31, 2023

Study Completion Date

October 31, 2023

Conditions
Lupus Nephritis
Interventions
BIOLOGICAL

ANX009

ANX009 will be administered per schedule specified in the arm description.

Trial Locations (7)

Unknown

Annexon Investigational Site 203, Angeles City

Annexon Investigational Site 204, Iloilo City

Annexon Investigational Site 201, Manila

Annexon Investigational Site 202, Quezon City

Annexon Investigational Site 101, Taichung

Annexon Investigational Site 102, Taipei

Annexon Investigational Site 103, Taoyuan

All Listed Sponsors
lead

Annexon, Inc.

INDUSTRY